247 related articles for article (PubMed ID: 34995924)
1. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.
Liu W; Tian L; Wu L; Chen H; Wang N; Liu X; Zhao C; Wu Z; Jiang X; Wu Q; Xu Z; Liu W; Zhao Q
Bioorg Chem; 2022 Dec; 129():106168. PubMed ID: 36191431
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease.
Wu X; Ze X; Qin S; Zhang B; Li X; Gong Q; Zhang H; Zhu Z; Xu J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675602
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease.
Yao H; Uras G; Zhang P; Xu S; Yin Y; Liu J; Qin S; Li X; Allen S; Bai R; Gong Q; Zhang H; Zhu Z; Xu J
J Med Chem; 2021 Jun; 64(11):7483-7506. PubMed ID: 34024109
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel α-carboline derivatives as glycogen synthase kinase-3β inhibitors for the treatment of Alzheimer's disease.
Chen H; Yu C; Liu W; Zhu C; Jiang X; Xu C; Liu W; Huang Y; Xu Z; Zhao Q
Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200156. PubMed ID: 35836098
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
Qiu J; Feng X; Chen H; Liu W; Liu W; Wu L; Gao X; Liu Y; Huang Y; Gong H; Qi Y; Xu Z; Zhao Q
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300404. PubMed ID: 38010470
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer's disease.
Jiang X; Wang Y; Liu C; Xing C; Wang Y; Lyu W; Wang S; Li Q; Chen T; Chen Y; Feng F; Liu W; Sun H
Bioorg Med Chem; 2021 Jan; 30():115940. PubMed ID: 33340937
[TBL] [Abstract][Full Text] [Related]
9. Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease.
Noori M; Dastyafteh N; Safapoor S; Khalili Ghomi M; Tanideh R; Zomorodian K; Hamedifar H; Dara M; Zare S; Irajie C; Javanshir S; Rastegar H; Panahi N; Larijani B; Mahdavi M; Hajimiri MH; Iraji A
Int J Biol Macromol; 2023 Dec; 253(Pt 7):127392. PubMed ID: 37827412
[TBL] [Abstract][Full Text] [Related]
10. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
[TBL] [Abstract][Full Text] [Related]
11. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.
Yang Y; Cheng X; Liu W; Chou G; Wang Z; Wang C
J Ethnopharmacol; 2015 Jun; 168():279-86. PubMed ID: 25862961
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
Liu W; Wu L; Liu W; Tian L; Chen H; Wu Z; Wang N; Liu X; Qiu J; Feng X; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Nov; 242():114689. PubMed ID: 36007469
[TBL] [Abstract][Full Text] [Related]
13. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
Shi XL; Wu JD; Liu P; Liu ZP
Eur J Med Chem; 2019 Apr; 167():211-225. PubMed ID: 30772605
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Zhao Y; Ye F; Xu J; Liao Q; Chen L; Zhang W; Sun H; Liu W; Feng F; Qu W
Bioorg Med Chem; 2018 Jul; 26(13):3812-3824. PubMed ID: 29960728
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
[TBL] [Abstract][Full Text] [Related]
18. Design, Bio-evaluation and Molecular Dynamics Simulation of Novel GSK-3β Inhibitors.
Lyu W; Li Q; Li Q; Chen Y; Wang Y; Tang T; Feng F; Chi H; Li Y; Liu W; Sun H
Mol Inform; 2021 Dec; 40(12):e2060031. PubMed ID: 34323388
[TBL] [Abstract][Full Text] [Related]
19. Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer's disease.
Du H; Song J; Ma F; Gao H; Zhao X; Mao R; He X; Yan Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2281893. PubMed ID: 37965884
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors.
Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L
Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
